ARAY
Price
$1.40
Change
-$0.06 (-4.11%)
Updated
Aug 15 closing price
Capitalization
144.22M
74 days until earnings call
BNGO
Price
$3.04
Change
-$0.17 (-5.30%)
Updated
Aug 15 closing price
Capitalization
10.23M
Interact to see
Advertisement

ARAY vs BNGO

Header iconARAY vs BNGO Comparison
Open Charts ARAY vs BNGOBanner chart's image
Accuray
Price$1.40
Change-$0.06 (-4.11%)
Volume$1.21M
Capitalization144.22M
Bionano Genomics
Price$3.04
Change-$0.17 (-5.30%)
Volume$188.46K
Capitalization10.23M
ARAY vs BNGO Comparison Chart in %
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. BNGO commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Hold and BNGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (ARAY: $1.40 vs. BNGO: $3.04)
Brand notoriety: ARAY and BNGO are both not notable
ARAY represents the Medical/Nursing Services, while BNGO is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ARAY: 154% vs. BNGO: 195%
Market capitalization -- ARAY: $144.22M vs. BNGO: $10.23M
ARAY [@Medical/Nursing Services] is valued at $144.22M. BNGO’s [@Pharmaceuticals: Other] market capitalization is $10.23M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.31B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileBNGO’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • BNGO’s FA Score: 0 green, 5 red.
According to our system of comparison, ARAY is a better buy in the long-term than BNGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 5 TA indicator(s) are bullish while BNGO’s TA Score has 6 bullish TA indicator(s).

  • ARAY’s TA Score: 5 bullish, 5 bearish.
  • BNGO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, BNGO is a better buy in the short-term than ARAY.

Price Growth

ARAY (@Medical/Nursing Services) experienced а +0.72% price change this week, while BNGO (@Pharmaceuticals: Other) price change was +4.47% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +4.58%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Reported Earning Dates

ARAY is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARAY($144M) has a higher market cap than BNGO($10.2M). ARAY YTD gains are higher at: -29.293 vs. BNGO (-82.432). ARAY has higher annual earnings (EBITDA): 20.6M vs. BNGO (-69.73M). ARAY has more cash in the bank: 77.8M vs. BNGO (18.2M). BNGO has less debt than ARAY: BNGO (18.4M) vs ARAY (214M). ARAY has higher revenues than BNGO: ARAY (465M) vs BNGO (28.5M).
ARAYBNGOARAY / BNGO
Capitalization144M10.2M1,412%
EBITDA20.6M-69.73M-30%
Gain YTD-29.293-82.43236%
P/E RatioN/A0.03-
Revenue465M28.5M1,632%
Total Cash77.8M18.2M427%
Total Debt214M18.4M1,163%
FUNDAMENTALS RATINGS
ARAY vs BNGO: Fundamental Ratings
ARAY
BNGO
OUTLOOK RATING
1..100
1163
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8898
PRICE GROWTH RATING
1..100
6190
P/E GROWTH RATING
1..100
4290
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for ARAY (85) in the Medical Specialties industry. This means that BNGO’s stock grew somewhat faster than ARAY’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's SMR Rating (88) in the Medical Specialties industry is in the same range as BNGO (98) in the Biotechnology industry. This means that ARAY’s stock grew similarly to BNGO’s over the last 12 months.

ARAY's Price Growth Rating (61) in the Medical Specialties industry is in the same range as BNGO (90) in the Biotechnology industry. This means that ARAY’s stock grew similarly to BNGO’s over the last 12 months.

ARAY's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for BNGO (90) in the Biotechnology industry. This means that ARAY’s stock grew somewhat faster than BNGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYBNGO
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRX9.450.06
+0.64%
Amneal Pharmaceuticals
BTBD1.60N/A
N/A
BT Brands
ASX9.83-0.11
-1.11%
ASE Technology Holding Co Ltd
AOUT9.65-0.12
-1.23%
American Outdoor Brands
FUFU3.77-0.20
-5.04%
BitFuFu

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with KIDS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-4.11%
KIDS - ARAY
42%
Loosely correlated
+0.31%
ILMN - ARAY
41%
Loosely correlated
+0.02%
A - ARAY
41%
Loosely correlated
+0.28%
ICUI - ARAY
40%
Loosely correlated
+8.09%
ITGR - ARAY
39%
Loosely correlated
+0.02%
More

BNGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNGO has been loosely correlated with MBOT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BNGO jumps, then MBOT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNGO
1D Price
Change %
BNGO100%
-5.30%
MBOT - BNGO
34%
Loosely correlated
-1.28%
CZMWY - BNGO
31%
Poorly correlated
+0.82%
ARAY - BNGO
30%
Poorly correlated
-4.11%
PACB - BNGO
29%
Poorly correlated
+6.50%
SONVY - BNGO
29%
Poorly correlated
+0.21%
More